Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00778375. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay
ClinicalTrials.gov study NCT01872819. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Daunorubicin + Cytarabine + Venetoclax in de Novo AML
ClinicalTrials.gov study NCT06697327. IPD Sharing: NO. Countries: 1. Publications: 0.
Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00480987. IPD Sharing: Not stated. Countries: 1. Publications: 0.
High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML
ClinicalTrials.gov study NCT02768792. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of I
ClinicalTrials.gov study NCT03850535. IPD Sharing: NO. Countries: 5. Publications: 0.
Safety and Activity of Digoxin With Decitabine in Adult AML and MDS
ClinicalTrials.gov study NCT03113071. IPD Sharing: NO. Countries: 1. Publications: 0.
A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B)
ClinicalTrials.gov study NCT01324063. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01468467. IPD Sharing: YES. Countries: 1. Publications: 0.
Sorafenib In Relapse of FMS-like Tyrosine Kinase 3 (FLT3)-Internal Tandem Duplication (ITD) AML Trial
ClinicalTrials.gov study NCT02867891. IPD Sharing: NO. Countries: 0. Publications: 2.
Busulfan and Fludarabine in Patients With AML and MDS
ClinicalTrials.gov study NCT00502905. IPD Sharing: Not stated. Countries: 1. Publications: 0.
FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04714372. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS
ClinicalTrials.gov study NCT00656448. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML
ClinicalTrials.gov study NCT00589082. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Alvocidib Biomarker-driven Phase 2 AML Study
ClinicalTrials.gov study NCT02520011. IPD Sharing: NO. Countries: 4. Publications: 0.
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06773208. IPD Sharing: YES. Countries: 1. Publications: 0.
T-Cell Depleted Double UCB for Refractory AML
ClinicalTrials.gov study NCT01464359. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT01160354. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML
ClinicalTrials.gov study NCT07374029. IPD Sharing: YES. Countries: 1. Publications: 0.
Revumenib in Combination With 7+3 + Midostaurin in AML
ClinicalTrials.gov study NCT06313437. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.